Stay updated with breaking news from Epic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DermTech, Inc. , a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the appointment of Mark Aguillard as chief commercial officer effective...
Breast Cancer Liquid Biopsy Market Forecast: Future Outlook and Industry Projections 2032
/PRNewswire/ -- The "Genomics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Fred Hutch biostatistician Dr. Ruth Etzioni received a seven-year Outstanding Investigator Award (OIA) from the National Cancer Institute to look at multi-cancer early detection tests, commonly referred to as liquid biopsies, and other novel diagnostic technologies..
The 56-gene ctDNA panel is a key component of DefineMBC™, the company’s comprehensive blood biopsy for metastatic breast cancerSAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. announced today that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (admi...